Citadel Advisors’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Buy |
1,179,543
+1,154,511
| +4,612% | +$2.53M | ﹤0.01% | 2458 |
|
|
2025
Q1 | $34K | Sell |
25,032
-391,740
| -94% | -$533K | ﹤0.01% | 5472 |
|
|
2024
Q4 | $554K | Buy |
+416,772
| New | +$554K | ﹤0.01% | 3894 |
|
|
2024
Q3 | – | Sell |
-3,085
| Closed | -$4.1K | – | 5786 |
|
|
2024
Q2 | $4.1K | Sell |
3,085
-304,741
| -99% | -$405K | ﹤0.01% | 5605 |
|
|
2024
Q1 | $606K | Sell |
307,826
-118,281
| -28% | -$233K | ﹤0.01% | 3689 |
|
|
2023
Q4 | $601K | Buy |
+426,107
| New | +$601K | ﹤0.01% | 3543 |
|
|
2023
Q3 | – | Sell |
-50,089
| Closed | -$86.2K | – | 5857 |
|
|
2023
Q2 | $86.2K | Buy |
50,089
+49,776
| +15,903% | +$85.6K | ﹤0.01% | 4815 |
|
|
2023
Q1 | $567 | Sell |
313
-12,590
| -98% | -$22.8K | ﹤0.01% | 5798 |
|
|
2022
Q4 | $34.3K | Sell |
12,903
-1,017,013
| -99% | -$2.71M | ﹤0.01% | 5398 |
|
|
2022
Q3 | $3.41M | Buy |
1,029,916
+754,242
| +274% | +$2.5M | ﹤0.01% | 2217 |
|
|
2022
Q2 | $1M | Buy |
275,674
+211,127
| +327% | +$768K | ﹤0.01% | 3393 |
|
|
2022
Q1 | $329K | Sell |
64,547
-584,028
| -90% | -$2.98M | ﹤0.01% | 4849 |
|
|
2021
Q4 | $4.95M | Sell |
648,575
-74,334
| -10% | -$567K | ﹤0.01% | 2110 |
|
|
2021
Q3 | $10.7M | Buy |
722,909
+71,421
| +11% | +$1.06M | ﹤0.01% | 1379 |
|
|
2021
Q2 | $12.1M | Buy |
+651,488
| New | +$12.1M | ﹤0.01% | 1303 |
|